Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis

por Zhou, Xumin, Liu, Jumei, Zhang, Jinming, Wei, Yong, Li, Hua
Publicado 2018

Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway

por Zhou, Xumin, Zhang, Jinming, Hu, Xiaoping, He, Peiqing, Guo, Jianyu, Li, Jun, Lan, Tian, Liu, Jumei, Peng, Lilan, Li, Hua
Publicado 2020

Hyaluronic acid modified covalent organic polymers for efficient targeted and oxygen-evolved phototherapy

por Shu, Fangpeng, Yang, Taowei, Zhang, Xuefeng, Chen, Wenbin, Wu, Kaihui, Luo, Junqi, Zhou, Xumin, Liu, Guochang, Lu, Jianming, Mao, Xiangming
Publicado 2021

Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis

por Chen, Wenbin, Cen, Shengren, Zhou, Xumin, Yang, Taowei, Wu, Kaihui, Zou, Libin, Luo, Junqi, Li, Chuanyin, Lv, Daojun, Mao, Xiangming
Publicado 2021

N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability

por Zou, Libin, Chen, Wenbin, Zhou, Xumin, Yang, Taowei, Luo, Junqi, Long, Zining, Wu, Jun, Lv, Daojun, Mao, Xiangming, Cen, Shengren
Publicado 2022

Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

por Zhong, Weibo, Wu, Kaihui, Long, Zining, Zhou, Xumin, Zhong, Chuanfan, Wang, Shuo, Lai, Houhua, Guo, Yufei, Lv, Daojun, Lu, Jianming, Mao, Xiangming
Publicado 2022

HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways

por Lv, Daojun, Wu, Huayan, Xing, Rongwei, Shu, Fangpeng, Lei, Bin, Lei, Chengyong, Zhou, Xumin, Wan, Bo, Yang, Yu, Zhong, Liren, Mao, Xiangming, Zou, Yaguang
Publicado 2017

HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis

por Zhou, Xumin, Li, Qi, He, Jincan, Zhong, Liren, Shu, Fangpeng, Xing, Rongwei, Lv, Daojun, Lei, Bin, Wan, Bo, Yang, Yu, Wu, Huayan, Mao, Xiangming, Zou, Yaguang
Publicado 2016

Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8(+) T cell-mediated ferroptosis in castration-resistant prostate cancer

por Zhou, Xumin, Zou, Libin, Liao, Hangyu, Luo, Junqi, Yang, Taowei, Wu, Jun, Chen, Wenbin, Wu, Kaihui, Cen, Shengren, Lv, Daojun, Shu, Fangpeng, Yang, Yu, Li, Chun, Li, Bingkun, Mao, Xiangming
Publicado 2022